false
OasisLMS
Catalog
A Practical Approach to COPD Patient – Part 2
GSK - Practical Aproach to COPD Patient - Part II
GSK - Practical Aproach to COPD Patient - Part II
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
In this video, Dr. David Menino and Dr. Gary Ferguson discuss the outpatient treatment of patients with COPD. They start by presenting a case of a woman in her 60s with COPD who recently had an exacerbation that required treatment with antibiotics and prednisone. They then talk about what constitutes an exacerbation and the triggers that can cause it. They emphasize the importance of identifying exacerbations as they can have negative impacts on patients' quality of life and increase the risk of cardiovascular events.<br /><br />The doctors also discuss various risk factors for exacerbations, such as lung function and eosinophil counts, and highlight the importance of assessing these factors to determine appropriate treatment options. They mention the IMPACT trial, which showed that triple therapy (inhaled corticosteroids, long-acting muscarinic antagonists, and long-acting beta-agonists) can significantly reduce exacerbations in high-risk patients.<br /><br />The video concludes with recommendations for treating exacerbations, including bronchodilators, systemic steroids, antibiotics, and non-invasive positive pressure ventilation. They emphasize the importance of chronic treatment, including smoking cessation, vaccinations, and rehabilitation programs.<br /><br />Overall, the video provides insights into the outpatient treatment of patients with COPD and highlights the importance of identifying and managing exacerbations to prevent negative outcomes.
Keywords
outpatient treatment
exacerbation
triggers
risk factors
treatment options
IMPACT trial
×
Please select your language
1
English